This Week’s CGT News: CRISPR/Cas9 improves ASOs efficacy, and more
July 2, 2025
Our latest news roundup reports on how CRISPR/Cas9 improves ASOs efficacy, Abbvie’s latest acquisition, further sickle cell disease research, and more
3 min read
False
Advertisement
July
Our latest biopharma news roundup reports on imlifidase for improved kidney transplant survival, the FDA’s Gamifant approval, AI-basd antibody discovery, and more
July 2, 2025
2 min read
New Weight-Loss Drug Aims for Results Without Harsh GI Effects
July 2, 2025
A new dual agonist GLP-1 is showing weight loss without gastrointestinal side effects and appetite suppression. We speak with the company to learn more.
3 min read
The Biosimulation Generation
July 1, 2025
Since the FDA announced plans to phase out mandatory animal testing, in silico drug discovery and development platforms are emerging. Welcome to the age of biosimulation.
6 min read
This Week’s Industry News, RFK Jr. criticizes Gavi, Trump Pulls Federal Subscriptions, and More
July 1, 2025
Our latest news roundup reports on thimerosal elimination, subscription termination, depression alleviation, and more
4 min read
Browse by Topics
Interviews
Cell & Gene
Bioprocessing
Drug Delivery
Drug Discovery
Development & Clinical
Formulation
Facilities & Equipment
Outsourcing
Packaging
Regulation & Standards
Small Molecules
Supply Chain
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blogs